Asthma

14 competing products in clinical development for Asthma.

Pipeline by Phase

Phase 25

Phase 37

Approved2

All Products (14)

Product	Company	Stage	Status	Hype
Dulera	Merck	Approved	Completed	43
Regadenoson + Placebo	Astellas Pharma	Approved	Completed	43
Roflumilast	AstraZeneca	Phase 3	Completed	40
Roflumilast	AstraZeneca	Phase 3	Completed	40
Omalizumab	Daiichi Sankyo	Phase 3	Completed	40
Omalizumab	Daiichi Sankyo	Phase 3	Completed	40
Zero-dose + 90 mcg of PROAIR® HFA + 180 mcg of 90 mcg of PROAIR® HFA + 90 mcg of albuterol sulfate inhalation aerosol	Sun Pharmaceutical	Phase 3	Completed	40
rabeprazole	Eisai	Phase 3	Completed	40
Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg + Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation Aerosol + Placebo	Cipla	Phase 3	Completed	40
YHD001 dose level 1 + YHD001 dose level 2 + Singulair + Placebo	Yuhan	Phase 2	Completed	35
Tacrolimus Inhalation Aerosol	Astellas Pharma	Phase 2	Completed	35
ONO-6950 + ONO-6950 + Montelukast + Placebo	Ono Pharmaceutical	Phase 2	Completed	35
ONO-6950 + Placebo + Montelukast	Ono Pharmaceutical	Phase 2	Completed	35
Placebo + Brodalumab	Kyowa Kirin	Phase 2	Terminated	27